Application of 1762-34-1. The mechanism of aromatic electrophilic substitution of aromatic heterocycles is consistent with that of benzene. Compound: 5,5′-Dimethyl-2,2′-bipyridine, is researched, Molecular C12H12N2, CAS is 1762-34-1, about Synthesis, crystal structures and biological activity of palladium(II) complexes with 1-methyl-1H-1,2,3,4-tetrazole-5-thiol and substituted 2,2′-bipyridines. Author is Rashidipour, Arezoo; Alizadeh, Robabeh; Sadeghi Mohammadi, Sanam; Tohidlou, Mohammad; Amani, Vahid; Seyfi, Sara.
Reaction of PdCl2 with 1-methyl-1H-1,2,3,4-tetrazole-5-thiol (Hmtzt) in the presence of 5,5′-dimethyl-2,2′-bipyridine (5,5′-dmbipy) and 4,4′-dimethyl-2,2′-bipyridine ligands (4,4′-dmbipy) afforded two new Pd(II) complexes, [Pd(5,5′-dmbipy)(mtzt)2] (1) and [Pd(4,4′-dmbipy)(mtzt)2] (2), resp. The two complexes were thoroughly characterized by elemental anal., UV-vis, 1H NMR, IR, luminescence spectroscopy as well as single-crystal X-ray diffraction. Single-crystal X-ray diffraction revealed that central Pd(II) ions in and are tetra-coordinated, presenting distorted and slightly distorted square planar geometry around Pd atom for and , resp. The luminescence properties of free ligands and complexes 1 and 2, in solution, were investigated. The biol. evaluation of the Pd(II) complexes showed that they exhibited anticancer activities in a dose-dependent manner against human breast cancer cell lines. Also, their in vitro interaction with DNA were analyzed through spectrophotometric, spectrofluorometric, and gel-electrophoresis which shows the intercalation mode of binding. In conclusion, these palladium complexes represent novel anticancer drug mols. for further study.
From this literature《Synthesis, crystal structures and biological activity of palladium(II) complexes with 1-methyl-1H-1,2,3,4-tetrazole-5-thiol and substituted 2,2′-bipyridines》,we know some information about this compound(1762-34-1)Application of 1762-34-1, but this is not all information, there are many literatures related to this compound(1762-34-1).